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Abstract Methionine, a sulfur amino acid, is the first amino acid that is required for many proteins, during 
synthesis. Our preliminary studies showed that this compound was produced during the late (post-stationary) 
secondary phase of growth. Therefore, restriction of methionine may be a useful strategy in limiting cancer growth. 
The bacterial strain used in this study was Citrobacter freundii (NRRL B-2643) and their vgb+ recombinant strain. A 
1/100 inoculum of overnight cultures grown in LB was made in 50 ml LB in 150 ml Erlenmeyer flasks. Inocula in 
flasks were grown for 24 h at 30 °C in a 200 rpm water-bath. For MGL production, 250 µL of this O/N culture was 
then inoculated into 150 mL conical flask containing 50 mL of sterile mineral salts medium supplemented with 1 % 
or 0.1 % (w/v) glucose, respectively. This was incubated for 96 h at 30 °C, 200 rpm on an orbital shaker. The highest 
MGL concentration (2,02) was reached by the recombinant strain of Cf[pUC8:15] 72 h after the start of incubation 
MM+0,1% glucose source. In comparison, the wild type strain produced 3,14 of MGL concentration 72 h was 
reached MM+0,1% glucose source. The poor media and secondary phase (72 h and up) was used to for MGL 
production. This is more appropriate. Plasmid is disadvantages in the secondary stage. 
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Introduction 
Cancer is a class of diseases characterized by out-of-
control cell growth. There are over 100 different types 
of cancer, and each is classified by the type of cell that 
is initially affected. Cancer is characterized by 
uncontrolled cellular growth as a result of changes in 
the expression of tumor promoting and tumor 
suppressing genes. A common feature of some cancers 
is the absolute requirement for methionine, a 
phenomenon known as ‘methionine dependence. 
Therefore, restriction of methionine may be a useful 
strategy in limiting cancer growth[1].  
Studies found that the methionine γ-lyase (MGL, EC 
4.4.1.11) can specifically split the methionine of 
extracellular and intracellular, so it can strongly inhibit 
the growth of tumor cells and induce apoptosis of tumor 
cells[1-2]. Many cancer cells have an absolute 
requirement for plasma methionine, whereas normal 
cells are relatively resistant to the restriction of 
exogenous methionine[3]. This allows one to consider 
MGL as a potential target for novel antibiotics [4]. Thus, 
therapeutic exploitation of C. freundii MGL to deplete 
plasma methionine has been extensively investigated[2, 
5]. Thus, when these tumor cells are deprived of 
methionine in homocysteine-containing medium in vitro, 
they reversibly arrest in the late S/G2 phase of the cell 
cycle. On another hand, MGL helps to inhibit the 
growth of mouse and human tumors in rodents and 
prolongs their survival[6]. Methionine- γ -lyase utilizes a 
pyridoxal-5’-phosphate-cofactor and catalyzes the 
degradation of L-methionine to α-ketobutyrate, 
methanethiol and ammonia[2]. MGL is proposed to be a 
potential drug target for treating anaerobic, parasitic 
infections[6-7]. Anaerobic bacteria and parasitic protozoa 
that possess MGL, rely on glycolysis and amino acid 
degradation for energy generation[2]. At the same time 
methionine also is required for the formation of the 
polyamines, spermine, and spermidine, which are 
necessary for cell proliferation[8]. The prospects of 
application of the enzyme as an antitumor agent were 
also demonstrated in vitro and in vivo. The possibility of 
using MLG for the therapy of Parkinson’s disease, 
atherosclerosis, aging, and obesity is discussed in 
work[7]. 
MGL has been detected Clostridiums porogenes, 
Pseudomonas ovalis, Pseudomonas putida, Aeromonas 
sp., Citrobacter intermedius, Brevibacterium linens, 
Citrobacter freundii, Porphyromonas gingivalis, and 
Treponema denticola, parasitic protozoa such as 
Trichomonas vaginalis, Entamoeba histolytica, and a 
model plant Arabidopsis thaliana. MGL activity was 
also detected from archae Ferroplasma acidarmanus, 
cheese surface bacteria such as Micrococcus luteus, 
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Arthrobacter sp., Corynebacterium glutamicum, and 
Staphylococcus equorum. Crystal structures have been 
reported from Pseudomonas putida, Citrobacter freundii, 
Trichomonas vaginalis, and Entamoeba histolytica. 
MGL is absent in mammalian cells[2-3, 7, 9-11]. 
The facultative anaerobic Citrobacter freundii, Gram-
negative and long rod-shaped bacterium belongs to the 
family of Enterobacteriaceae, and can be found in 
water, food and the intestinal tracts of animals and 
humans. As an opportunistic pathogen, C. freundii is 
responsible for a number of significant opportunistic 
infections, such infections of the respiratory tract, 
urinary tract and blood[12]. 
The obligate aerobic bacterium, Vitreoscilla, 
synthesizes elevated quantities of Vitreoscilla 
hemoglobin (VHb) under hypoxic growth conditions. 
Expression of VHb in heterologous hosts often 
enhances growth and product formation. A role in 
facilitating oxygen transfer to the respiratory 
membranes is one explanation of its cellular function[13]. 
In this study, the production of MGL by C. freundii 
was studied in different culture medium. The goal of 
this work was to obtain insight into how MGL 
stimulates of different culture conditions by C. freundii 
and pUC8:15. 
Materials and Methods 
Materials 
Methionine (Aldrich); PLP, mercaptoethanol (Sigma), 
EDTA (Applichem), TCA (Across), 3-MBTH (Merck); 
sodium acetate (Riedel-de Haen), potassium phosphate 
and di-potassium phosphate (Sigma). All other 
chemicals used in this study were of analytical reagent 
grade or the highest grade commercially available. 
Bacterial strain and culture conditions 
The bacterial strain used in this study was 
Citrobacter freundii (NRRL B-2643) and their vgb+ 
recombinant strain. C. freundii was transformed with 
vgb carrying recombinant plasmid pUC8:15, the cells 
were maintained on LB agar plates at 4 ºC with transfers 
at monthly intervals. The liquid media used throughout 
the study were Luria-Bertani (LB) broth and M9 
minimal medium (MM) containing (per liter); 6 g 
Na2HPO4, 3 g KH2PO4, 0.5 g NaCl, 1 g NH4Cl. The 
final pH values of both media were adjusted to 7.0.  
Growth conditions 
Cells were maintained on Luria- Bertani (LB) (Miller, 
1972) agar plates at 4 °C with transfers at monthly 
intervals. A 1/100 inoculum of overnight cultures grown 
in LB was made in 50 ml LB in 150 ml Erlenmeyer 
flasks. Inocula in flasks were grown for 24 h at 30 °C in 
a 200 rpm water-bath. C. freundii strains were routinely 
grown on Luria- Bertani medium (LB). Minimal 
medium (M9 Minimal media (MM)) contained 1 % and 
0.1 % glucose, added from a stock solution respectively, 
autoclaved. LBG medium contained 1 % and 0.1 % 
glucose. The growth characteristics of both wild C. 
freundii and its recombinants in the rich (LB) and in the 
nutrient restricted nutritional (MM) media were 
monitored at the given intervals during the course of the 
experiments. For MGL production, 250 µL of this O/N 
culture was then inoculated into 150 mL conical flask 
containing 50 mL of sterile mineral salts medium 
supplemented with 1 % or 0.1 % (w/v) glucose, 
respectively. This was incubated for 96 h at 30 °C, 200 
rpm on an orbital shaker. 
For MGL production and assay 
For MGL production, 250 µl of this O/N culture was 
then inoculated into 150 ml conical flask containing 50 
ml of sterile mineral salts medium supplemented with 
1% or 0.1% (w/v) glucose, respectively. This was 
incubated for 96 h at 30 °C, 200 rpm on an orbital 
shaker.  Recombinant MGL activity was determined by 
the method described[14-15]. The absorbance measured at 
320 nm a unit’s enzyme. One unit of enzyme activity 
was determined as the amount of enzyme catalyzing 
transformation of 1 μmol of L-methionine per minute 
pH 8.0 at 37 °C. 
Results 
The intracellular MGL level was determined cultures 
harvested at 96 h. Our preliminary studies showed that 
this compound was produced during the late (post-
stationary) secondary phase of growth (Figure 1 b, 2 b, 
3 b, 4 b, 5 b). On further incubation (e.g., 72 h and up), 
a substantial decrease in MGL production was observed. 
In LB and LBG-grown cultures, the intracellular MGL 
level of recombinant strain Cf [pUC 8:15] was 
substantially higher than that of wild type bacteria, 
especially 48 h and up. The cell density in MM was 
significantly lower than in complex LB medium. When 
glucose was used as a carbon source, the recombinant 
strain was observed decrease both cell density and 
specific activity. In MM-grown cultures, the 
intracellular MGL level of wild-type strains of C. 
freundii was substantially higher than that of their 
recombinant Cf [pUC 8:15] strain (Figure 3-5 b). 
Although to a lesser extent, the intracellular levels of 
MGL for the wild-type strain of were also higher than 
for their recombinant counterparts.


































































































Table 1. pH Values of 96th h. 
Figure 1. Total cell mass (a) and (b) intracellular MGL levels of C. freundii and their Cf [pUC 8:15] harboring recombinant grown in LB medium for 
24-96 h. Each value is the average of three independent experiments.
Figure 2. Total cell mass (a) and (b) intracellular MGL levels of C. freundii and their Cf [pUC 8:15] harboring recombinant grown in LB+0.1% glucose 
medium for 24-96 h. Each value is the average of three independent experiments.  
Figure 3. Total cell mass (a) and (b) intracellular MGL levels of C. freundii and their Cf [pUC 8:15] harboring recombinant grown in LB+1% glucose 










Cf  Wild 9,01 9,09 4,27 6,76 5,74 
Cf [pUC 8:15] 9,14 9,14 4,39 6,71 5,03 


































































Figure 4. Total cell mass (a) and (b) intracellular MGL levels of C. freundii and their Cf [pUC 8:15] harboring recombinant grown in MM+0.1% 
glucose medium for 24-96 h. Each value is the average of three independent experiments.  
Figure 5. Total cell mass (a) and (b) intracellular MGL levels of C. freundii and their Cf [pUC 8:15] harboring recombinant grown in MM+1% glucose 
medium for 24-96 h. Each value is the average of three independent experiments.  
Hüseyin Kahraman. Effect of Vitreoscilla hemoglobin on production anti-tumor enzyme methionine -γ-lyase, 
by Citrobacter freundii
138 
On further incubation a substantial increase in total 
cell masses (OD600 values) were observed (Figure 1 a, 
3-5 a). On the other hand, the lower levels of 
intracellular MGL production and total cell mass in 
recombinant bacteria Cf [pUC 8:15] may be due to 
plasmid burden on cells. Especially vgb bearing 
recombinant strain Cf [pUC 8:15] had higher total cell 
mass levels than the wild type strain (Figure 3-5a). 
These findings are in agreement with those from 
previous studies showing that the dramatic effect of 
VHb on cell metabolism and production formation is 
found under limited oxygen conditions where an 
elevated expression of VHb occurs[16]. In C. freundii 
and its recombinants, there was inverse relationship 
between the total cell mass and intracellular product 
level; the highest product formation was observed in 
cultures with lowest total cell mass (Figure 2 a, b and 3 
a, b). In LB and LB +1% glucose-grown cultures, the 
intracellular MGL level of recombinant strain 
Cf[pUC8:15] was substantially higher than that of their 
respective wild- strain C. freundii (Figure 1-3 b) On 
other hand in MM- grown cultures, the intracellular 
MGL level of wild-type strains of C. freundii was 
substantially higher than that of their respective 
recombinant strain  Cf[pUC8:15] (Figure 4-5 b). The 
highest MGL concentration (2,02) was reached by the 
recombinant strain of Cf[pUC8:15] 72 h after the start 
of incubation MM+0,1% glucose source (Figure 4 b). In 
comparison, the wild type strain produced 3,14 of MGL 
concentration 72 h was reached MM+0,1% glucose 
source (Figure 4 b). In C. freundii and its recombinants, 
there was inverse relationship between the total cell 
mass and intracellular product level; the highest product 
formation was observed in cultures with lowest total cell 
mass (Figure 4 a, b). Glucose rate is increased, the pH is 
reduced. The presence of glucose 1% decreases pH 
values (Table 1). Low pH values in MM may reduce the 
enzyme activity, in particular recombinant bacteria. 
Discussion 
Industrial biotechnology is becoming increasingly 
important as the unique metabolic capacities of 
microbes offer new enzymes. MGL is one of a few 
microbial enzymes with high therapeutic value in 
certain kinds of cancers, where it is used to “starve” 
cancer cells of amino acid L-methionine. A 
characteristic feature of many solid tumors is their 
requirement for exogenous methionine in order to 
proliferate whereas normal cells are generally 
methionine independent[17]. Therefore, restriction of 
methionine may be a useful strategy in limiting cancer 
growth[1]. On further incubation (e.g., 48 h and up), a 
substantial increase in MGL production was observed. 
All in growth medium after 48 hours there is an 
increase in enzyme activity. Lower intracellular MGL 
levels of Cf[pUC8:15] may also be due to a higher 
metabolic burden inflicted by the presence of high 
copy-number this plasmid[16]. In C. freundii and its 
recombinant strain Cf[pUC8:15], there was inverse 
relationship between the total cell mass and 
intracellular product level; the highest product 
formation was observed in cultures with lowest total 
cell mass (Figure 2-4 b). MGL production of all media 
started after the all phase and generally leveled at 72 h. 
However, the MGL production was affected by the rich 
media LB and LB + Glucose. The lower levels of 
intracellular MGL in recombinant bacteria Cf [pUC 
8:15] may be due to plasmid burden on cells. In 
addition, glucose rate in culture conditions significantly 
affected the rate of cell mass and MGL production. 
Especially, low pH values in MM may reduce the 
enzyme activity, in particular recombinant bacteria 
(Table 1). Oxygen deficiency that develops in the 
fermentation with a low oxygen transfer rate has 
significant effects, such as low viable cell number 
which results low product yield[16].  
Conclusion 
This is indicated the poor media and secondary 
phase (72 h and up) was used to MGL production. 
Short term production of MGL recombinant bacteria is 
advantageous. Plasmids are disadvantages in the 
secondary stage. 
In MM-grown cultures, the intracellular MGL level 
of wild-type strain and their recombinant was 
substantially higher than that their culture conditions. 
In addition, glucose rate in culture conditions 
significantly affected the rate of cell mass and MGL 
production. The effect of plasmid-mediated metabolic 
burden on the expression of the host genes has been the  
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